Idera Pharma Reports Presentation of New Intratumoral IMO-2125 Preclinical Data at CRI-CIMT-EATI-AACR Conference
September 16, 2015 at 09:04 AM EDT
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical-stage biopharmaceutical company developing Toll-like receptor (TLR) and RNA ...
